Mohammed Milhem, MBBS discussed the mechanism of action of RP1, the design and preliminary findings of the IGNYTE trial in ...

An investigational viral immunotherapy extended survival compared with standard care for patients with advanced non-small cell lung cancer who had inadequate response to immune checkpoint inhibitor ...

Efforts to estimate the reproducibility of published research results have focused on specific areas of research to date, ...

Patients with certain types of early stage cancer, particularly those affecting the gastrointestinal system, may be able to ...

A McGill University-led research collaboration has achieved a breakthrough in understanding how cancer spreads. A clinical ...

Cell therapy is considered by some as the next frontier in cancer treatment, engineering patients' own immune systems to attack cancer.

A new study found that the immunotherapy treatment worked against some types of cancers, allowing patients to avoid surgery ...

Cells have a mailing system of sorts. They can release tiny molecular balls, called extracellular vesicles (EVs), that ...

Ethris GmbH, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics and vaccines, today announced that it was awarded a ?10 million grant from EU4Health, the EU's largest ...